Evidence map›Paper›PMID 34003333›Full record

ReviewCurrent microbiology2021

Natural Products of the Fungal Genus Humicola: Diversity, Biological Activity, and Industrial Importance.

Sabrin R M Ibrahim, Shaimaa G A Mohamed, Ahmed E Altyar, Gamal A Mohamed

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Benefits ofMicroorganisms · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. TwoMicroorganisms · 2023
    Article
  11. Article
  12. Review
  13. Molecules (Basel, Switzerland) · 2022
    Review
  14. Journal of fungi (Basel, Switzerland) · 2022
    Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Bright Side ofJournal of fungi (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Sabrin R M IbrahimBatterjee Medical College, North Obhur, Prince Abdullah Al-Faisal Street, P.O. Box 6231, Jeddah, 21442, Saudi Arabia. sabrin.ibrahim@bmc.edu.sa.
Shaimaa G A MohamedFaculty of Dentistry, British University, El Sherouk City, Suez Desert Road, Cairo, 11837, Egypt.
Ahmed E AltyarDepartment of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.
Gamal A MohamedDepartment of Natural Products and Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.
Al-Azhar University · EGBatterjee Medical CollegeBritish University in Egypt · EGKing Abdulaziz University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fungal metabolites are worthily taken into account as a pool of synthetically interesting and remarkably important new lead compounds for medical, agricultural, and chemical industries. Humicola species are known to have biotechnological and industrial potentials. Humicola genus (family Chaetomiaceae) is a prosperous fountainhead of unique and structurally diverse metabolites that have various bioactivities. Moreover, Humicola species attract substantial attention for their marked ability to produce thermostable enzymes with biotechnological and industrial importance. This review highlights the published researches on the isolated metabolites from the genus Humicola and their biological activities as well as the industrial importance of Humicola species. In the current review, more than 50 compounds are described and 84 references are cited.

Indexed as

Biological ProductsBiodiversityBiotechnologyFungal Genus HumicolaFungiBiological Products

Identifiers

PMID34003333
OpenAlexW3163459839

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.